Clinical Trial Update: The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta

View source ↗

Summary

The clinical trial evaluating fetal fibronectin to predict delivery in placental abruption has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Placental Abruption

Snippet

Sponsor: Winthrop University Hospital | Conditions: Pregnancy Related, Trauma | Status: TERMINATED